Solidion Technology Inc (STI) Stock’s -0.93% Decrease This Year: What’s the Story?
Solidion Technology Inc (STI) Stock Trading Recap On Friday, Solidion Technology Inc (STI) stock saw a decline, ending the day at $0.41 which represents a decrease of $-0.02 or -4.65% from the prior close of $0.43. The stock opened at $0.44 and touched a low of $0.39 during the day, reaching a high of $0.44. […]
DA Davidson Issues Neutral Rating for Hain Celestial Group Inc (HAIN) Stock
DA Davidson has recently initiated Hain Celestial Group Inc (HAIN) stock to Neutral rating, as announced on March 1, 2024, according to Finviz. Earlier, on February 8, 2024, Maxim Group had reiterated the stock to Buy, setting a price target of $18 for HAIN stock. Stephens also initiated Overweight rating with a price target of […]
Uncover the Reason: Why Revance Therapeutics Inc (RVNC) Stock Is Trading 57.39% Above Its 52-Week Low?
Mizuho has recently reduced Revance Therapeutics Inc (RVNC) stock to Neutral rating, as announced on January 29, 2024, according to Finviz. Earlier, on January 9, 2024, Goldman had reduced the stock from a Buy to Neutral, setting a price target of $8 for RVNC stock. Exane BNP Paribas also raised Neutral rating with a price […]
What’s Causing Viracta Therapeutics Inc (VIRX) Stock’s -79.70% Drop Over the Last Six Months?
Leerink Partners has recently reduced Viracta Therapeutics Inc (VIRX) stock to Market Perform rating, as announced on August 16, 2024, according to Finviz. Earlier, on February 1, 2022, RBC Capital Mkts had initiated the stock to Outperform, setting a price target of $10. H.C. Wainwright also initiated Buy rating with a price target of $35. […]
Why Did Ironwood Pharmaceuticals, Inc. (IRWD) Stock Surge 5.69% Last Week?
Leerink Partners has recently initiated Ironwood Pharmaceuticals, Inc. (IRWD) stock to Market Perform rating, as announced on September 9, 2024, according to Finviz. Earlier, on August 8, 2024, CapitalOne had reduced the stock from a Overweight to Equal Weight, setting a price target of $4 for IRWD stock. Craig Hallum also initiated Buy rating with […]
Tevogen Bio Holdings Inc (TVGN) Stock: More Strategic Than Meets the Eye
Tevogen Bio Holdings Inc (TVGN) Stock Trading Recap On Friday, Tevogen Bio Holdings Inc (TVGN) stock saw a decline, ending the day at $1.32 which represents a decrease of $-0.05 or -3.65% from the prior close of $1.37. The stock opened at $1.39 and touched a low of $1.28 during the day, reaching a high […]
What’s Fueling Hayward Holdings Inc (HAYW) Stock’s 9.31% Gain Above Its 200-Day SMA?
Jefferies has recently reduced Hayward Holdings Inc (HAYW) stock to Hold rating, as announced on January 11, 2024, according to Finviz. Earlier, on December 20, 2023, Stifel had reduced the stock from a Buy to Hold, setting a price target of $13.50 for HAYW stock. Stifel also raised Buy rating with a price target of […]
Surgery Partners Inc (SGRY) Posted -2.03% Profit Margin Last Year—Can It Hold Up?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Nextgen Digital Platforms Ord Shs (NXT) Reported a 25.48% Operating Margin Last Year—What’s the Real Story?
Northland Capital has recently resumed Nextgen Digital Platforms Ord Shs (NXT) stock to Outperform rating, as announced on November 19, 2024, according to Finviz. Earlier, on September 4, 2024, Jefferies had initiated the stock to Hold, setting a price target of $46. Susquehanna also initiated Positive rating with a price target of $59. Additionally, Fox […]
What’s Driving Bloomin’ Brands Inc (BLMN) Stock’s -19.04% Plunge Over the Past Month?
Raymond James has recently reduced Bloomin’ Brands Inc (BLMN) stock to Mkt Perform rating, as announced on November 11, 2024, according to Finviz. Earlier, on January 23, 2024, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $26. Raymond James also reduced Outperform rating with a price target […]